Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-002508
Filing Date
2023-01-05
Accepted
2023-01-05 17:08:34
Documents
12
Period of Report
2022-10-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d424199d8ka.htm   iXBRL 8-K/A 24453
  Complete submission text file 0001193125-23-002508.txt   157712

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amrn-20221020.xsd EX-101.SCH 2516
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20221020_lab.xml EX-101.LAB 20039
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20221020_pre.xml EX-101.PRE 12513
6 EXTRACTED XBRL INSTANCE DOCUMENT d424199d8ka_htm.xml XML 4621
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-21392 | Film No.: 23512374
SIC: 2834 Pharmaceutical Preparations